- Home
- KRRO vs BANX Comparison
KRRO vs BANX Comparison
Compare KRRO & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- BANX
- Stock Information
- Founded
- KRRO 2014
- BANX 2013
- Country
- KRRO United States
- BANX United States
- Employees
- KRRO N/A
- BANX N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- BANX Trusts Except Educational Religious and Charitable
- Sector
- KRRO Health Care
- BANX Finance
- Exchange
- KRRO Nasdaq
- BANX Nasdaq
- Market Cap
- KRRO 125.4M
- BANX 146.9M
- IPO Year
- KRRO 2019
- BANX N/A
- Fundamental
- Price
- KRRO $12.90
- BANX $21.02
- Analyst Decision
- KRRO Strong Buy
- BANX
- Analyst Count
- KRRO 7
- BANX 0
- Target Price
- KRRO $85.67
- BANX N/A
- AVG Volume (30 Days)
- KRRO 99.7K
- BANX 23.4K
- Earning Date
- KRRO 08-12-2025
- BANX 06-17-2025
- Dividend Yield
- KRRO N/A
- BANX 9.66%
- EPS Growth
- KRRO N/A
- BANX N/A
- EPS
- KRRO N/A
- BANX 2.35
- Revenue
- KRRO $4,821,000.00
- BANX $29,467,794.00
- Revenue This Year
- KRRO $65.08
- BANX N/A
- Revenue Next Year
- KRRO N/A
- BANX N/A
- P/E Ratio
- KRRO N/A
- BANX $8.88
- Revenue Growth
- KRRO N/A
- BANX 2.73
- 52 Week Low
- KRRO $10.29
- BANX $17.99
- 52 Week High
- KRRO $98.00
- BANX $21.67
- Technical
- Relative Strength Index (RSI)
- KRRO 51.40
- BANX 57.31
- Support Level
- KRRO $12.27
- BANX $20.60
- Resistance Level
- KRRO $15.15
- BANX $21.24
- Average True Range (ATR)
- KRRO 1.13
- BANX 0.34
- MACD
- KRRO 0.25
- BANX 0.01
- Stochastic Oscillator
- KRRO 57.01
- BANX 77.32
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.